Deletion of IL-6 or its cognate receptor gp130 in AOM/DSS model resulted in reduced tumor size and tumor number, whereas further potentiation of STAT3 activity by introducing hyper-active gp130 led to increased tumor diameter and tumor count [15], [16]. Here, IL6 is linked to neoplasm.